Altrinsic Global Advisors’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-321,360
Closed -$2.57M 69
2021
Q4
$2.57M Hold
321,360
0.08% 55
2021
Q3
$2.69M Hold
321,360
0.08% 59
2021
Q2
$2.17M Hold
321,360
0.07% 63
2021
Q1
$2.12M Buy
321,360
+80,000
+33% +$529K 0.07% 65
2020
Q4
$1.01M Buy
241,360
+20,000
+9% +$84K 0.03% 73
2020
Q3
$1.06M Hold
221,360
0.04% 69
2020
Q2
$1.35M Hold
221,360
0.06% 65
2020
Q1
$1.22M Hold
221,360
0.07% 62
2019
Q4
$2.19M Buy
221,360
+20,000
+10% +$198K 0.09% 54
2019
Q3
$1.16M Hold
201,360
0.05% 66
2019
Q2
$1.83M Buy
201,360
+2,300
+1% +$20.9K 0.08% 58
2019
Q1
$2.76M Buy
199,060
+17,700
+10% +$246K 0.13% 49
2018
Q4
$2.86M Sell
181,360
-10,000
-5% -$158K 0.14% 51
2018
Q3
$3.7M Hold
191,360
0.17% 50
2018
Q2
$1.4M Hold
191,360
0.06% 69
2018
Q1
$588K Hold
191,360
0.02% 79
2017
Q4
$617K Hold
191,360
0.02% 81
2017
Q3
$928K Hold
191,360
0.04% 74
2017
Q2
$995K Hold
191,360
0.04% 78
2017
Q1
$957K Sell
191,360
-19,196
-9% -$96K 0.03% 76
2016
Q4
$1.03M Hold
210,556
0.04% 75
2016
Q3
$1.4M Buy
210,556
+5,556
+3% +$37K 0.05% 70
2016
Q2
$992K Hold
205,000
0.03% 74
2016
Q1
$1M Hold
205,000
0.03% 76
2015
Q4
$1.78M Buy
205,000
+100,000
+95% +$868K 0.05% 75
2015
Q3
$1.53M Buy
105,000
+7,110
+7% +$104K 0.04% 75
2015
Q2
$1.63M Buy
97,890
+44,454
+83% +$741K 0.03% 78
2015
Q1
$1.17M Buy
+53,436
New +$1.17M 0.03% 76